| An immunogenic personal neoantigen vaccine for patients with melanoma PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym, W Zhang, A Luoma, ... Nature 547 (7662), 217-221, 2017 | 2824 | 2017 |
| Biology and clinical relevance of human natural killer cells MJ Robertson, J Ritz | 1367 | 1990 |
| Interleukin-2 and regulatory T cells in graft-versus-host disease J Koreth, K Matsuoka, HT Kim, SM McDonough, B Bindra, EP Alyea III, ... New England Journal of Medicine 365 (22), 2055-2066, 2011 | 1280 | 2011 |
| Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial DB Keskin, AJ Anandappa, J Sun, I Tirosh, ND Mathewson, S Li, ... Nature 565 (7738), 234-239, 2019 | 1265 | 2019 |
| Activation of a novel human transforming gene, ret, by DNA rearrangement M Takahashi, J Ritz, GM Cooper Cell 42 (2), 581-588, 1985 | 1100 | 1985 |
| IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo E Zorn, EA Nelson, M Mohseni, F Porcheray, H Kim, D Litsa, R Bellucci, ... Blood 108 (5), 1571-1579, 2006 | 957 | 2006 |
| Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ... New England Journal of Medicine 325 (22), 1525-1533, 1991 | 886 | 1991 |
| Expression of Epstein–Barr virus transformation–associated genes in tissues of patients with EBV lymphoproliferative disease L Young, C Alfieri, K Hennessy, H Evans, C O'Hara, KC Anderson, J Ritz, ... New England Journal of Medicine 321 (16), 1080-1085, 1989 | 886 | 1989 |
| A monoclonal antibody to human acute lymphoblastic leukaemia antigen J Ritz, JM Pesando, J Notis-McConarty, H Lazarus, SF Schlossman Nature 283 (5747), 583-585, 1980 | 873 | 1980 |
| The elusive nature and function of mesenchymal stem cells C Nombela-Arrieta, J Ritz, LE Silberstein Nature reviews Molecular cell biology 12 (2), 126-131, 2011 | 861 | 2011 |
| Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. MB Atkins, MJ Robertson, M Gordon, MT Lotze, M DeCoste, JS DuBois, ... Clinical cancer research: an official journal of the American Association …, 1997 | 760 | 1997 |
| Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. EL Reinherz, PC Kung, JM Pesando, J Ritz, G Goldstein, SF Schlossman The Journal of experimental medicine 150 (6), 1472-1482, 1979 | 716 | 1979 |
| CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation J Deng, ES Wang, RW Jenkins, S Li, R Dries, K Yates, S Chhabra, ... Cancer discovery 8 (2), 216-233, 2018 | 661 | 2018 |
| Expression of myeloid differentiation antigens on normal and malignant myeloid cells. JD Griffin, J Ritz, LM Nadler, SF Schlossman The Journal of clinical investigation 68 (4), 932-941, 1981 | 631 | 1981 |
| Ipilimumab for patients with relapse after allogeneic transplantation MS Davids, HT Kim, P Bachireddy, C Costello, R Liguori, A Savell, ... New England Journal of Medicine 375 (2), 143-153, 2016 | 608 | 2016 |
| Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease E Zorn, HT Kim, SJ Lee, BH Floyd, D Litsa, S Arumugarajah, R Bellucci, ... Blood 106 (8), 2903-2911, 2005 | 586 | 2005 |
| Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer J Nemunaitis, SN Rabinowe, JW Singer, PJ Bierman, JM Vose, ... New England Journal of Medicine 324 (25), 1773-1778, 1991 | 583 | 1991 |
| Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. MA Caligiuri, A Zmuidzinas, TJ Manley, H Levine, KA Smith, J Ritz The Journal of experimental medicine 171 (5), 1509-1526, 1990 | 560 | 1990 |
| Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease K Matsuoka, J Koreth, HT Kim, G Bascug, S McDonough, Y Kawano, ... Science translational medicine 5 (179), 179ra43-179ra43, 2013 | 542 | 2013 |
| Rituximab for steroid-refractory chronic graft-versus-host disease C Cutler, D Miklos, HT Kim, N Treister, SB Woo, D Bienfang, LB Klickstein, ... Blood 108 (2), 756-762, 2006 | 518 | 2006 |
Robert SoifferProfessor of Medicine Harvard Medical Schooldfci.harvard.edu의 이메일 확인됨
